BackAtara Biotherapeutics Overview

Atara Biotherapeutics Intangible Assets

Atara Biotherapeutics's intangible assets is $0.

Get informed when a big investor buys or sells

+ Follow
Intangible Assets
$0.00

Peer trimmed avg / median

Loading

Atara Biotherapeutics Intangible Assets History

Loading

Atara Biotherapeutics vs. peers: Intangible Assets Comparison

Loading

Atara Biotherapeutics Intangible Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Atara Biotherapeutics (ATRA) FAQ

As of the most recent data (March 2026), ATRA shows a intangible assets of $0. In the prior-year period, the figure was $0. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, ATRA's intangible assets is now $0 (was $0). Pairing that YoY change with peer averages gives a clearer picture of whether Atara Biotherapeutics is outperforming or lagging.

Tracking ATRA's intangible assets over time shows whether Atara Biotherapeutics is scaling, shrinking, or reshaping that part of the business. The current reading is $0 In the prior-year period, the figure was $0. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this intangible assets page, Stockcircle has Atara Biotherapeutics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect intangible assets (currently $0) with ownership activity and broader fundamentals.

Atara Biotherapeutics's intangible assets is $0; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.